Latest Slides

Filter Science News

LBCT Shortcuts

Sunday, Nov. 4, 2012 Monday, Nov 5, 2012 Tuesday, Nov. 6, 2012

LBCT.01: Practice Implications for CAD and VTE

LBCT.03: Treatments for Prevention of Cardiovascular Events: A Population Perspective

LBCT.05: Cell-Based Therapies for Myocardial Regeneration

LBCT.02: Health Economics and Quality of Life in Contemporary Trials

LBCT.04: Novel Treatments for Managing Lipid Disorders

LBCT.06: Management of LV Dysfunction: Devices and Drugs


Science News from AHA12

A doctor who presented research on the importance of CPR during the American Heart Association’s resuscitation conference in Chicago proved her point hours later, saving a man who collapsed in a hotel lobby. Monique Anderson, M.D., was talking with another doctor about the importance of fast response to cardiac emergencies while leaving a... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2014 9:00 AM CST
LBCT.04: Ischemic Heart Disease: Drugs, Devices and Systems of Care   Overview of LBCT.04: Elliott Antman, MD; Mariell Jessup, MD; Clyde Yancy, MD; Robert Bonow, MD   Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a... more...
Posted by Summer H. on AHA Scientific Sessions Nov 19, 2014 12:26 PM CST
LBCT.03: Treatment of Structural Heart Disease   Overview of LBCT.03: Elliott Antman, MD; Robert Bonow, MD; Clyde Yancy, MD   Randomized Trial of Atenolol Versus Losartan in Children and Young Adults With Marfan Syndrome Presentation Slides (PDF) | Summary Slide (PDF) | Abstract... more...
Posted by Summer H. on AHA Scientific Sessions Nov 18, 2014 11:51 AM CST
Science and Technology Hall was again a flurry of activity during Scientific Sessions 2014 in Chicago. Speaking of flurries, the snow continued to dance in the air and the thermometer read 18 degrees for most of the day. Inside, we were all staying warm, learning CPR to the beat of "Stayin' Alive" and showing our support of Go Red for... more...
Posted by Summer H. on AHA Scientific Sessions Nov 17, 2014 5:50 PM CST
LBCT.02: Anti-Lipid Therapy and Prevention of CAD   Overview of LBCT.02: Elliott Antman, MD; Neil Stone, MD; Clyde Yancy, MD     IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes ... more...
Posted by Summer H. on AHA Scientific Sessions Nov 17, 2014 11:23 AM CST
There was snow and frozen yogurt and a packed room for opening remarks. There were chair massages and cashmere scarves and even a couple of stock cars in Exhibition Hall.  Scientific Sessions 2014 is officially underway in Chicago!  The new Life Is Why slogan welcomes attendees to Sessions. Attendees stroll around... more...
Posted by Summer H. on AHA Scientific Sessions Nov 16, 2014 5:15 PM CST
LBCT.01: Risk and Benefit of Dual Antiplatelet Therapy Overview of LBCT.01: Elliott Antman, President, American Heart Association   Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study... more...
Posted by Summer H. on AHA Scientific Sessions Nov 16, 2014 4:41 PM CST
Early PCI Is Associated with Short- and Long-Term Outcome After Out-of-Hospital Cardiac Arrest  Presentation Slides Guillaume Geri -- Cochin Hospital, Paris, France more...
Posted by Summer H. on AHA Scientific Sessions Nov 16, 2014 11:16 AM CST
Statewide Implementation of a Standardized Prearrival Telephone CPR Program Is Associated with Increased Bystander CPR and Survival from Out-of-Hospital Cardiac Arrest  Presentation Slides Bentley Bobrow -- Arizona Department of Health Services,Phoenix, AZ more...
Posted by Summer H. on AHA Scientific Sessions Nov 16, 2014 11:08 AM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Douglas L. Mann Washington University School of Medicine, Barnes Jewish Hospital St. Louis, MO   A Multicenter, Randomized Study Assessing the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Advanced Heart... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 3:33 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Joerg Schwab University of Bonn Bonn, Germany   Dedicated ICD Programming Reduces the Number of Inappropriate Therapies in a Real World Primary Prevention ICD Population: The DECREASE - Trial   Presentation Slides | Abstract |... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 3:25 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Jeffrey H. Lawson Duke University Durham, NC   First-in-Man Clinical Evaluation of a Novel Tissue Engineered Vascular Graft   Presentation Slides  | Abstract | Presentation Audio | Discussant Audio | Discussant Slides ... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 3:10 PM CST
CS.04: Advanced Cardiovascular Disease: Complications and Challenges   Amy Sarma Brigham and Women's Hospital  Boston, MA   The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy after an Acute Coronary Syndrome   Presentation Slides |... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 3:02 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Michael J. Koren Jacksonville Center for Clinical Research Jacksonville, FL   Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145 versus Standard of Care in 1104 Patients: 52-week Results... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 1:23 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Arshed Ali Quyyumi Emory University Atlanta, GA   Effect of Angiotensin II Type I Receptor Blockade on Carotid Artery Atherosclerosis: A Randomized Trial Comparing Valsartan and Placebo (EFFERVESCENT)    Presentation... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 1:10 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Thomas J Wang Vanderbilt University Nashville, TN   Daylight: Vitamin D Therapy in Individuals at High Risk of Hypertension    Presentation Slides | Abstract | Presentation Audio | Discussant Audio | Discussant Slides ... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 12:50 PM CST
CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis   Tobias Bonten Leiden University Medical Center Leiden, Netherlands   Does Aspirin Intake at Bedtime Decrease Blood Pressure and Morning Peak of Platelet Reactivity?: A Randomized Cross-over Trial    Presentation Slides |... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 12:11 PM CST
CS.02: Biomarkers in Populations   Lijing L. Yan The George Institute for Global Health at Peking University Health Science Center Beijing, China   China Rural Health Initiative - Primary Care Provider Study: A Large Cluster-Randomized Controlled Trial of High Cardiovascular Risk Management in Rural China ... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 11:53 AM CST
CS.02: Biomarkers in Populations   Jack V. Tu Institute for Clinical Evaluative Sciences Toronto, ON, Canada   Ten-Year Incidence Rates of Major Cardiovascular Events in 697,690 Immigrants to Ontario, Canada, by Ethnic Group and Country of Birth   Presentation Slides  | Abstract | Presentation... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 11:34 AM CST
CS.02: Biomarkers in Populations   Stella Aslibekyan University of Alabama at Birmingham Birmingham, AL   CPT1A Methylation is a Novel Epigenetic Marker of Cardiovascular Risk    Presentation Slides  | Abstract | Presentation Audio | Discussant Slides | Discussant Audio   ... more...
Posted by Summer H. on AHA Scientific Sessions Nov 20, 2013 11:15 AM CST